CONSENT OF INDEPENDENT AUDITORS
Published on April 2, 2001
EXHIBIT 23
INDEPENDENT AUDITORS' CONSENT
The Board of Directors
Cytoclonal Pharmaceutics Inc.
We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (333-37049), Post-Effective Amendment No. 1 to Form S-8
(No. 333-37049), Form S-8 (No. 333-11691), Post-Effective Amendment No. 2 to
Form SB-2 on Form S-3 (No. 333-13409), Form S-3 (No. 333-66003), Form S-3 (No.
333-25323), Post-Effective Amendments Nos. 5 to 8 to Form SB-2 (No. 333-91802),
Form S-8 (No. 333-86201), and Amendments Nos. 1 and 2 to Form S-3 (No.
333-33838) of Cytoclonal Pharmaceutics Inc. of our report dated March 2, 2001,
with respect to the financial statements of Cytoclonal Pharmaceutics Inc.
included in this annual report on Form 10-K for the year ended December 31,
2000.
Richard A. Eisner & Company, LLP
New York, New York
March 28, 2001